Mentor: Dr. Laura E. Dreer, Assistant Professor, Director of Psychological & Neuropsychological Clinical Research Services, CEH 200, University of Alabama at Birmingham 35294-0009. Telephone: (205) 325-8681; Email: email@example.com
Postdoctoral position is available in Dr. Laura Dreer's clinical research program.
Dr. Dreer is a licensed clinical researcher with a Ph.D. in clinical psychology and specialty expertise in medical rehabilitation psychology and neuropsychology. Her research program focuses on adjustment related issues relevant to patients and family caregivers living with chronic health conditions such as vision impairments, military related injuries, head injuries, and seizures/epilepsy to name just a few. Additionally, her research focuses on developing health promotion and cognitive behavioral therapy interventions/programs to improve health outcomes.
The research will be focused on these areas in terms of project coordination, preparation of scientific manuscripts, grant submissions, and data analyses. Individuals with experience in project coordination, scientific publication, national presentations, and grant preparation are highly preferred as well as a background in health promotion, medical rehabilitation, and/or mental health research. Highly motivated individuals with a background in these areas are strongly encouraged to apply, particularly experience with publications and managing clinical trials in human research. Please send a CV, a brief statement of research interests and career goals, and a list of 3 references with contact information to: Dr. Laura Dreer at firstname.lastname@example.org.
Postdocs in UAB News
Called the Institutional Training Grant Program in Genomic Medicine, the initiative has awarded $3.5 million in five-year grants to research institutes to provide genomics training to postdoctoral fellows who have earned an MD or PhD.
The program is the first of its kind to incorporate research and medical training in genomics.
Nicholas Dionne-Odom, Ph.D., will use a five-year, $935,000 award to research and develop a health-coaching program to support family caregivers for persons with advanced cancer and help them stay healthy and functioning at a high level.
UAB Research News
Two experimental drugs that block LRRK2 kinase enzyme were shown to lessen aggregations of alpha synuclein protein, which have been shown to play a role in the development of Parkinson's disease, report researchers at the University of Alabama Birmingham.
Kelly Nichols, O.D., Ph.D., a dry eye expert and dean of the University of Alabama at Birmingham School of Optometry, conducted research studies for the parent drug company to explore the efficacy and safety of lifitegrast in treating this eye condition that affects more than 16 million adults in the United States.